FdaApplication
ANDA 204057
Identifiers
- fda_app_no: ANDA204057
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK SPECIALTY SA |
| application_type | ANDA |
| approval_date | 2016-02-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NORGESTIMATE AND ETHINYL ESTRADIOL | ETHINYL ESTRADIOL; NORGESTIMATE | 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG | TABLET;ORAL-28 |
1 product